Report cover image

Mycoplasma Testing Market Size - By Technology, By Product & Services, By Distribution Channel, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Publisher SPER Market Research Pvt. Ltd.
Published Dec 16, 2022
Length 233 Pages
SKU # SPER18001331

Description

Mycoplasma Testing Market Size - By Technology, By Product & Services, By Distribution Channel, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2032


Global Mycoplasma Testing Market Overview:

According to SPER Market Research, the Global Mycoplasma Testing Market is estimated to reach USD 3.05 billion by 2032 with a CAGR of 13.43%. In essence, mycoplasma testing is a type of medical test done by medical experts to help you quickly identify or exclude mycoplasma contamination of your cell cultures. This strategy entails a series of examinations that evaluate the blood antibodies created in response to a mycoplasma infection or that directly identify the organism through culture or by detecting its genetic material (DNA) in a body sample.

Impact of COVID-19 on the Global Mycoplasma Testing Market

Mycoplasma testing services are in high demand because to the corona virus pandemic and the discovery of Mycoplasma pneumoniae in SARS-CoV-2 patients. This is mostly because patients with pre-existing medical illnesses have difficulties such as cytokine, autoimmune activation and hemodynamic malfunction, mitochondrial dysfunction, and other symptoms that are difficult to treat.

Scope of the Report:

Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032

Segments covered By Technology, By Product & Services, By Distribution Channel, By Application, By End Use

Regions covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered Agilent Technologies, American Type Culture Collection, Asahi Kasei Medical Co. Ltd., Biological Industries Israel Beit Haemek Ltd., Bionique Testing Laboratories Inc., Biotools B & M Labs, Charles River Laboratories International Inc.

Global Mycoplasma Testing Market Segmentation:

By Product & Services:Based on the Product& Services, Global Mycoplasma Testing Market is segmented as;Assays, Kits, & Reagents (Elimination Kits, ELISA Assays, Kits, & Reagents, Nucleic Acid, Detection Kits, PCR Assay, Stains, Standards & Controls, Others), Instruments, Services.

By End Use:Based on the End Use, Global Mycoplasma Testing Market is segmented as;Academic Research Institutes, Cell Banks & Laboratories, Clinics, Community Healthcare, Contract Research Organizations, Hospitals and Surgical Centers, Oncology Centers, Pharmaceutical & Biotechnology Companies, Others.

By Region:North America owns the prime share of this market; the major factors of the market's growth in the region is this industry is anticipated to gain its market share because of its well-established healthcare industry and the rising prevalence of respiratory ailments.

Table of Contents

233 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Mycoplasma Testing Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Mycoplasma Testing Market, By Technology, 2019-2032 (USD Million)
6.1. Direct Assay
6.2. DNA Staining
6.3. ELISA
6.4. Enzymatic Methods
6.5. Indirect Assay
6.6. PCR
6.7. Others
7. Global Mycoplasma Testing Market, By Product& Services, 2019-2032 (USD Million)
7.1. Assays, Kits& Reagents
7.1.1. Elimination Kits
7.1.2. ELISA Assays, Kits, & Reagents
7.1.3. Nucleic Acid Detection Kits
7.1.4. PCR Assay
7.1.5. Stains
7.1.6. Standards & Controls
7.1.7. Others
7.2. Instruments
7.3. Services
8. Global Mycoplasma Testing Market, By Distribution Channel, 2019-2032 (USD Million)
8.1. Direct Tenders
8.2. Retail
9. Global Mycoplasma Testing Market,By Application, 2019-2032 (USD Million)
9.1. Cell Line Testing
9.2. End-Of-Production Cell Testing
9.3. Virus Testing
9.4. Others
10. Global Mycoplasma Testing Market, By End Use, 2019-2032 (USD Million)
10.1 Academic Research Institutes
10.2 Cell Banks & Laboratories
10.3 Clinics
10.4 Community Healthcare
10.5 Contract Research Organizations
10.6 Hospitals and Surgical Centers
10.7 Oncology Centers
10.8 Pharmaceutical & Biotechnology Companies
10.9 Others
11. Global Mycoplasma Testing Market, By Region, 2019-2032 (USD Million)
11.1 North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2 Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3 Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4 South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of South America
11.5 Middle East & Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Rest of Middle East & Africa
12. Company Profiles
12.1 Agilent Technologies
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2 American Type Culture Collection
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3 Asahi Kasei Medical Co. Ltd.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4 Biological Industries Israel Beit Haemek Ltd.
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5 Bionique Testing Laboratories Inc.
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6 Biotools B & M Labs
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7 Charles River Laboratories International Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8 Clongen Laboratories Inc.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9 Creative Bioarray
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10 Eurofins Scientific
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11 GenBio
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12 GeneCopoeia Inc.
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13 InvivoGen
12.13.1. Company details
12.13.2. Financial outlook
12.13.3. Product summary
12.13.4. Recent developments
12.14 Lonza Group Ltd.
12.14.1. Company details
12.14.2. Financial outlook
12.14.3. Product summary
12.14.4. Recent developments
12.15 Merck KGaA
12.15.1. Company details
12.15.2. Financial outlook
12.15.3. Product summary
12.15.4. Recent developments
12.16 Meridian Bioscience Inc.
12.16.1. Company details
12.16.2. Financial outlook
12.16.3. Product summary
12.16.4. Recent developments
12.17 Minerva Biolabs GmbH
12.17.1. Company details
12.17.2. Financial outlook
12.17.3. Product summary
12.17.4. Recent developments
12.18 Mycoplasma Experience
12.18.1. Company details
12.18.2. Financial outlook
12.18.3. Product summary
12.18.4. Recent developments
12.19 Nelson Laboratories Fairfield Inc.
12.19.1. Company details
12.19.2. Financial outlook
12.19.3. Product summary
12.19.4. Recent developments
12.20 NorgenBiotek Corp.
12.20.1. Company details
12.20.2. Financial outlook
12.20.3. Product summary
12.20.4. Recent developments
12.21 PromoCell GmbH
12.21.1. Company details
12.21.2. Financial outlook
12.21.3. Product summary
12.21.4. Recent developments
12.22 Roche Diagnostics
12.22.1. Company details
12.22.2. Financial outlook
12.22.3. Product summary
12.22.4. Recent developments
12.23 Sartorius AG
12.23.1. Company details
12.23.2. Financial outlook
12.23.3. Product summary
12.23.4. Recent developments
12.24 Savyon Diagnostics
12.24.1. Company details
12.24.2. Financial outlook
12.24.3. Product summary
12.24.4. Recent developments
12.25 ScienCell Research Laboratories Inc.
12.25.1. Company details
12.25.2. Financial outlook
12.25.3. Product summary
12.25.4. Recent developments
12.26 Thermo Fisher Scientific Inc.
12.26.1. Company details
12.26.2. Financial outlook
12.26.3. Product summary
12.26.4. Recent developments

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us